ATHEROGENICS INC (WKN: 936248 kaufenswert)

Seite 1 von 1
neuester Beitrag: 04.02.08 20:56
eröffnet am: 04.02.08 20:56 von: wikki 1 Anzahl Beiträge: 1
neuester Beitrag: 04.02.08 20:56 von: wikki 1 Leser gesamt: 1016
davon Heute: 1
bewertet mit 0 Sternen

04.02.08 20:56

1337 Postings, 4652 Tage wikki 1ATHEROGENICS INC (WKN: 936248 kaufenswert)

24.04.07 19:33 (HUGIN)
AtheroGenics to Present at Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2007
23.04.07 08:00 (HUGIN)
AtheroGenics and AstraZeneca End Collaboration Agreement for AGI-1067
16.04.07 22:01 (HUGIN)
AtheroGenics to Report First Quarter 2007 Financial Results on April 26, 2007
27.03.07 15:30 (HUGIN)
AtheroGenics Announces ARISE Phase III Clinical Study Results at the American College of Cardiology's 56th Annual Scientific Session
23.03.07 22:55 (HUGIN)
AtheroGenics Schedules Conference Call and Webcast to Discuss ARISE Phase III Clinical Trial Results
19.03.07 11:31 (HUGIN)
AtheroGenics Announces Conference Call to Provide Business Update
19.03.07 11:30 (HUGIN)
AtheroGenics Reports ARISE Trial Results for AGI-1067
16.02.07 22:38 (HUGIN)
AtheroGenics to Report 2006 Fourth Quarter and Full-Year Financial Results on February 22, 2007  

   Antwort einfügen - nach oben